Physician profile
Wayne W Beam
NPI 1073548921
$11,500.35
in general payments reported to CMS, 2019-2025
54 companies · $1,134 in 2025
The $1,134 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,547 · 2020: $947 · 2021: $1,601 · 2022: $2,081 · 2023: $1,734 · 2024: $1,456 · 2025: $1,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,250 · Education: $45.00 · Entertainment: $28.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,250.19 |
| Education | $45.00 |
| Entertainment | $28.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,152.70 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,318.22 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals Lp | $899.07 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $742.77 | 2019-2025 | |
| Lilly USA, LLC | $697.69 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $505.82 | 2019-2025 | Jardiance |
| Amgen INC. | $480.43 | 2019-2025 | Evenity, Aimovig |
| Merck Sharp & Dohme LLC | $375.03 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Sanofi-Aventis U.S. LLC | $306.16 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $298.86 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $284.89 | 2022-2025 | Rexulti |
| Astellas Pharma US INC | $278.19 | 2019-2024 | Veozah, Myrbetriq |
| Takeda Pharmaceuticals U.S.A., INC. | $257.52 | 2020-2024 | Trintellix |
| Exact Sciences Corporation | $237.78 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $233.17 | 2019-2023 | Spravato |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $232.15 | 2019-2025 | Xifaxan, Trulance |
| Currax Pharmaceuticals LLC | $188.07 | 2020-2024 | Contrave |
| Glaxosmithkline, LLC. | $177.76 | 2019-2024 | Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $158.74 | 2019-2021 | |
| Allergan, INC. | $133.77 | 2019-2020 | |
| Mylan Specialty L.P. | $130.92 | 2023-2024 | Yupelri |
| Abbott Laboratories | $118.67 | 2021-2025 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $114.35 | 2019-2021 | |
| Axsome Therapeutics, INC. | $107.45 | 2023 | Auvelity |
| Medtronic, INC. | $93.70 | 2022-2024 | Minimed 780g |
| Neurelis, INC. | $63.06 | 2023 | Valtoco |
| Ironshore Pharmaceuticals INC. | $62.43 | 2019-2020 | |
| Radius Health, INC. | $61.93 | 2019 | |
| Qol Medical, LLC | $58.42 | 2023 | Sucraid |
| E.R. Squibb & Sons, L.L.C. | $56.56 | 2019-2022 | |
| Inspire Medical Systems, INC. | $55.06 | 2023-2024 | Inspire |
| Biohaven Pharmaceutical Holding Company Ltd. | $51.49 | 2022 | |
| Corcept Therapeutics | $46.65 | 2025 | Korlym |
| Verona Pharma, INC. | $45.10 | 2025 | Ohtuvayre |
| Nestle Healthcare Nutrition INC. | $42.35 | 2021 | |
| Collegium Pharmaceutical, INC. | $40.95 | 2025 | Jornay Pm |
| Vital Connect, INC | $39.42 | 2023 | Vitalpatch Rtm |
| Xeris Pharmaceuticals, INC. | $38.71 | 2022-2023 | Gvoke Hypopen |
| Biohaven Pharmaceuticals, INC. | $35.92 | 2021 | |
| Optos, INC. | $28.80 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Circassia INC. | $28.30 | 2020 | |
| Neuronetics, INC. | $23.69 | 2025 | Neurostar Tms Therapy System |
| Baxter Healthcare | $20.19 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Cranial Technologies, INC | $19.57 | 2023 | Doc Band |
| Hikma Pharmaceuticals USA | $18.09 | 2021 | |
| Eyevance Pharmaceuticals LLC | $18.09 | 2021 | |
| Boston Scientific Corporation | $17.66 | 2025 | Watchman Access System |
| Esperion Therapeutics, INC. | $16.58 | 2021 | |
| Viatris Specialty LLC | $16.20 | 2025 | Yupelri |
| Shield Therapeutics INC | $15.53 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $15.40 | 2022 | |
| Alexion Pharmaceuticals, INC. | $14.82 | 2024 | Strensiq |
| Amarin Pharma, INC. | $12.90 | 2019 | |
| Genentech USA, INC. | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Beam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.